Clinical trial
Study for the Treatment of Crohn's Disease With Adacolumn
NCT00162942 · Otsuka America Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00162942 |
|---|---|
| Title | Study for the Treatment of Crohn's Disease With Adacolumn |
| Official title | A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Crohn's Disease |
| Lead sponsor | Otsuka America Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Device |
| Interventions | Adacolumn, Sham |
| Enrollment | 235 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 13, 2005 |
| Last update posted | Apr 7, 2009 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: